http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-8604911-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_324beb8b942a3a6ed1f1f576bcd76c45
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
filingDate 1983-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1986-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-8604911-A1
titleOfInvention PROCESS TO PREPARE A DERIVATIVE OF PIPERAZINE.
abstract PROCESS FOR THE PREPARATION OF A PIPERAZINE DERIVATIVE, REPRESENTED BY THE GENERAL FORMULA (I), IN WHICH R1 IS A HYDROGEN ATOM OR A LOWER ALKYL GROUP; R2 IS A HYDROXYL GROUP OR AN ARALKYLOXIDE GROUP; R3 IS A HYDROGEN ATOM; AND R4 IS A HYDROGEN ATOM OR LOWER ALCOXYL GROUP, AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS. IT INCLUDES THE FOLLOWING OPERATIONS: FIRST, A COMPOUND OF GENERAL FORMULA (II) IS ADDED TO A SOLVENT; SECOND, THE COMPOUND OF GENERAL FORMULA (II) IS REDUCED, AT A TEMPERATURE INCLUDED BETWEEN ZERO AND THE BOILING POINT OF THE SOLVENT, BY MEANS OF AN ACTION OF REDUCING AGENT; AND FINALLY, IT BECOMES A DERIVATIVE OF PIPERAZINE SO OBTAINED, IN THE CORRESPONDING SALT. OF APPLICATION IN THE PREPARATION OF A DRUG CAPABLE OF IMPROVING BRAIN CIRCULATION.
priorityDate 1982-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974

Total number of triples: 21.